DMAC4:30 PMDiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business HighlightsResults Call • Phase 2Results call Tue, Sep 1, 2026, 4:30 PM EDTGdiamedica.com
DMAC4:30 PMDiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026diamedica.com
DMAC8:30 AMDiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth RestrictionTrial Start • Phase 2Trial initiation Tue, Jun 23, 2026, 8:30 AM EDTGdiamedica.com